Corporate commotion


The likely direction of future regulation for the over-the-counter (OTC) derivatives market is causing ructions among some major corporates, which are concerned they may face higher hedging charges. These higher costs, they argue, could restrict their ability to do business and have a negative effect on the real economy.

Corporations are worried because policy-makers plan to introduce higher capital charges for counterparties engaging in bespoke OTC derivatives transactions than for similar

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

If you already have an account, please sign in here.


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here